Derived neutrophil/lymphocyte ratio predicts gemcitabine therapy outcome in unresectable pancreatic cancerRei Suzuki, Hiromasa Ohira, Tadayuki Takagi et al.|Oncology Letters|2016Cited by 50
Cutting Edge: Role of MASP-3 in the Physiological Activation of Factor D of the Alternative Complement PathwayManabu Hayashi, Hideharu Sekine, Takeshi Machida et al.|The Journal of Immunology|2019Cited by 50
Feasibility of esophageal stent fixation with an over-the-scope-clip for malignant esophageal strictures to prevent migrationKo Watanabe, Hiromasa Ohira, Takuto Hikichi et al.|Endoscopy International Open|2017Cited by 35
Endoscopic submucosal dissection for early gastric cancer in very elderly patients age 85 or olderKo Watanabe, Hiromasa Ohira, Takuto Hikichi et al.|Endoscopy International Open|2017Cited by 33
Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patientsMitsuru Sugimoto, Hiromasa Ohira, Ryoichiro Kobashi et al.|BMC Cancer|2021Cited by 33